Skip to main content
. Author manuscript; available in PMC: 2014 Oct 22.
Published in final edited form as: Psoriasis Forum. 2010 Summer;16(2):36–42.

Figure 1.

Figure 1

Median Psoriasis Area and Severity Index (PASI) with infliximab treatment at weeks 0, 2, and 6.

(Adapted with permission from Gottlieb AB, Evans R, Li S, Dooley LT, Guzzo CA, Baker D, et al. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol. 2004;51:534–42.)